These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11211336)

  • 41. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 45. HIV resistance: the new enemy.
    Colvin R
    Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial comment: a plethora or options in multidrug-resistant HIV-1 infection.
    Katzenstein DA
    AIDS Read; 2008 Sep; 18(9):478-9. PubMed ID: 18828232
    [No Abstract]   [Full Text] [Related]  

  • 47. Simplifying drug regimens.
    HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substitution for protease inhibitors in HIV therapy.
    Mikhail E
    N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602
    [No Abstract]   [Full Text] [Related]  

  • 49. Delavirdine dilemma at the FDA. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiretroviral rounds. Resistance: what you don't know--can it hurt you?
    Gathe JC; Elion R
    AIDS Clin Care; 2008 Jun; 20(6):51-2. PubMed ID: 18661634
    [No Abstract]   [Full Text] [Related]  

  • 51. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New pediatric dosing recommendations for atazanavir.
    AIDS Patient Care STDS; 2008 Apr; 22(4):347. PubMed ID: 18434948
    [No Abstract]   [Full Text] [Related]  

  • 53. ICAAC clinical trials review available.
    AIDS Treat News; 2002 Oct; (384):5. PubMed ID: 12434763
    [No Abstract]   [Full Text] [Related]  

  • 54. Report from the 12th Retrovirus Conference. Adherence.
    Friedland GH; Nagy GS
    AIDS Clin Care; 2005 Apr; 17(4):36. PubMed ID: 15875309
    [No Abstract]   [Full Text] [Related]  

  • 55. Man of the Year. Hope with an asterisk.
    Lacayo R
    Time; 1996 Dec 30-1997 Jan 6; 148(29):82-5. PubMed ID: 10163846
    [No Abstract]   [Full Text] [Related]  

  • 56. DHHS issues adult guideline revisions.
    Bartlett JG;
    Hopkins HIV Rep; 2004 Jan; 16(1):1, 5. PubMed ID: 14989190
    [No Abstract]   [Full Text] [Related]  

  • 57. Protease inhibitor boosting is complex, requires thorough knowledge of interactions.
    Monier P
    HIV Clin; 2004; 16(3):1-3. PubMed ID: 15366104
    [No Abstract]   [Full Text] [Related]  

  • 58. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Introduction.
    TreatmentUpdate; 2003; 15(3):1. PubMed ID: 17216843
    [No Abstract]   [Full Text] [Related]  

  • 59. Report from ICAAC: new drugs and antiretroviral therapy for naïve patients.
    Gallant JE
    Hopkins HIV Rep; 2002 Nov; 14(6):1-3, 7. PubMed ID: 12491989
    [No Abstract]   [Full Text] [Related]  

  • 60. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes.
    Albrecht H
    J Watch AIDS Clin Care; 2009 Oct; 21(10):82. PubMed ID: 20458813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.